Vertex Pharmaceuticals Incorporated Stock
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
426.9 USD | -0.71% | +3.91% | +4.76% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
Financials (USD)
Sales 2024 * | 10.75B | Sales 2025 * | 11.67B | Capitalization | 111B |
---|---|---|---|---|---|
Net income 2024 * | 3.99B | Net income 2025 * | 4.46B | EV / Sales 2024 * | 9.02 x |
Net cash position 2024 * | 13.97B | Net cash position 2025 * | 19.01B | EV / Sales 2025 * | 7.88 x |
P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
25.1
x | Employees | 5,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Vertex Pharmaceuticals Incorporated
1 day | -1.61% | ||
1 week | +3.31% | ||
Current month | +7.89% | ||
1 month | +6.66% | ||
3 months | +1.42% | ||
6 months | +14.56% | ||
Current year | +4.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 17-01-31 | |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 19-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 17-06-07 |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Bruce Sachs
BRD | Director/Board Member | 64 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 426.3 | -0.84% | 424 562 |
24-05-13 | 429.9 | +1.69% | 939,753 |
24-05-10 | 422.8 | +0.90% | 1,064,604 |
24-05-09 | 419 | +0.04% | 676,185 |
24-05-08 | 418.8 | +2.09% | 1,651,673 |
Delayed Quote Nasdaq, May 14, 2024 at 11:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.16% | 111B | |
+11.42% | 105B | |
-12.58% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.80% | 16.96B | |
+2.58% | 13.7B | |
+36.62% | 12.45B | |
+288.74% | 7.98B |
- Stock Market
- Equities
- VRTX Stock